NCT02250976View on ClinicalTrials.gov

The Pharmacokinetic Study of the Fixed-dose Combination of Micronized Fenofibrate and Pitavastatin Ca

PHASE1CompletedINTERVENTIONAL
Enrollment

41

Participants

Timeline

Start Date

September 30, 2014

Primary Completion Date

October 31, 2014

Study Completion Date

October 31, 2014

Conditions
Healthy Male Volunteers
Interventions
DRUG

Livasupril Cap.160/2mg

Fenofibrate pellet( as micronized fenofibrate 160mg) and Pitavastatin Ca 2mg

DRUG

Lipilfen cap. 160mg

Micronized fenofibrate 160mg

DRUG

Livaro tab. 2mg

Pitavastatin Ca 2mg

Trial Locations (1)

700-721

Kyungpook National University Hospital, Daegu

All Listed Sponsors
lead

Hanlim Pharm. Co., Ltd.

INDUSTRY

NCT02250976 - The Pharmacokinetic Study of the Fixed-dose Combination of Micronized Fenofibrate and Pitavastatin Ca | Biotech Hunter | Biotech Hunter